These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22472915)

  • 41. Cost-effectiveness of clopidogrel plus aspirin for stroke prevention in patients with atrial fibrillation in whom warfarin is unsuitable.
    Coleman CI; Straznitskas AD; Sobieraj DM; Kluger J; Anglade MW
    Am J Cardiol; 2012 Apr; 109(7):1020-5. PubMed ID: 22221944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
    Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
    Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparing Strategies for Lipid Lowering in Argentina: An Analysis from the CVD Policy Model-Argentina.
    Konfino J; Fernandez A; Penko J; Mason A; Martinez E; Coxson P; Heller D; Moran A; Bibbins-Domingo K; Pérez-Stable EJ; Mejía R
    J Gen Intern Med; 2017 May; 32(5):524-533. PubMed ID: 27853916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70-100 mg/dL in Taiwan.
    Lin FJ; Shyu KG; Hsieh IC; Huey-Herng Sheu W; Tu ST; Yeh SJ; Chen CI; Lu KC; Wu CC; Shau WY; Inocencio TJ; Wen YC; Yeh HI
    J Formos Med Assoc; 2020 May; 119(5):907-916. PubMed ID: 32081563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Statin's cost-effectiveness: a Canadian analysis of commonly prescribed generic and brand name statins.
    Tran YB; Frial T; Miller PS
    Can J Clin Pharmacol; 2007; 14(2):e205-14. PubMed ID: 17556788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-Effectiveness of Evolocumab in Adult Patients with Atherosclerotic Cardiovascular Disease from Chinese Healthcare Perspective.
    Xie W; Song Y; Qin X; Jin P
    Adv Ther; 2023 Feb; 40(2):489-503. PubMed ID: 36371480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determinants of the cost-effectiveness of statins.
    Morrison A; Glassberg H
    J Manag Care Pharm; 2003; 9(6):544-51. PubMed ID: 14664662
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Impact of Rapid Reduction of Low-Density Lipoprotein Cholesterol Level on Long-Term Outcome of Acute Myocardial Infarction in the Statin Era: Subanalysis of the ALPS-AMI Study.
    Miura T; Izawa A; Motoki H; Miyashita Y; Kashima Y; Ebisawa S; Tomita T; Koyama J; Ikeda U
    PLoS One; 2015; 10(6):e0127835. PubMed ID: 26083546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States.
    Chen CX; Hay JW
    Int J Cardiol; 2015 Feb; 181():417-24. PubMed ID: 25569270
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?
    Bangalore S; Fayyad R; Kastelein JJ; Laskey R; Amarenco P; DeMicco DA; Waters DD
    Am J Med; 2016 Apr; 129(4):384-91. PubMed ID: 26551986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness of adding ezetimibe to atorvastatin vs switching to rosuvastatin therapy in Portugal.
    Laires PA; Ejzykowicz F; Hsu TY; Ambegaonkar B; Davies G
    J Med Econ; 2015; 18(8):565-72. PubMed ID: 25788039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate- and low-cardiovascular-risk individuals for statin therapy.
    Lee KK; Cipriano LE; Owens DK; Go AS; Hlatky MA
    Circulation; 2010 Oct; 122(15):1478-87. PubMed ID: 20876434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States.
    Odden MC; Pletcher MJ; Coxson PG; Thekkethala D; Guzman D; Heller D; Goldman L; Bibbins-Domingo K
    Ann Intern Med; 2015 Apr; 162(8):533-41. PubMed ID: 25894023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Carroll C; Tappenden P; Rafia R; Hamilton J; Chambers D; Clowes M; Durrington P; Qureshi N; Wierzbicki AS
    Pharmacoeconomics; 2017 May; 35(5):537-547. PubMed ID: 28285379
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intensive statin therapy for Indians: Part-I. Benefits.
    Enas EA; Pazhoor HC; Kuruvila A; Vijayaraghavan K
    Indian Heart J; 2011; 63(3):211-27. PubMed ID: 22734339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statin Therapy in Low-Risk Air Force Aviators with Isolated Hypercholesterolemia.
    Tvaryanas AP; Mahaney HJ; Schroeder VM; Maupin GM
    Aerosp Med Hum Perform; 2017 Aug; 88(8):752-759. PubMed ID: 28720185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effectiveness of echocardiography to identify intracardiac thrombus among patients with first stroke or transient ischemic attack.
    Meenan RT; Saha S; Chou R; Swarztrauber K; Pyle Krages K; O'Keeffe-Rosetti MC; McDonagh M; Chan BK; Hornbrook MC; Helfand M
    Med Decis Making; 2007; 27(2):161-77. PubMed ID: 17409366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease.
    Kohli-Lynch CN; Lewsey J; Boyd KA; French DD; Jordan N; Moran AE; Sattar N; Preiss D; Briggs AH
    Circulation; 2022 Apr; 145(17):1312-1323. PubMed ID: 35249370
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effectiveness of population-wide genomic screening for familial hypercholesterolemia in the United States.
    Spencer SJ; Jones LK; Guzauskas GF; Hao J; Williams MS; Peterson JF; Veenstra DL
    J Clin Lipidol; 2022; 16(5):667-675. PubMed ID: 35961838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integrating a Polygenic Risk Score for Coronary Artery Disease as a Risk-Enhancing Factor in the Pooled Cohort Equation: A Cost-Effectiveness Analysis Study.
    Mujwara D; Henno G; Vernon ST; Peng S; Di Domenico P; Schroeder B; Busby GB; Figtree GA; Bottà G
    J Am Heart Assoc; 2022 Jun; 11(12):e025236. PubMed ID: 35699184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.